Gilead Sciences to Acquire Hookipa’s HB-400 and HB-500 Vaccine Programs
US-based Gilead Sciences Inc. (Nasdaq: GILD) announced plans to acquire the HB-400 and HB-500 programs...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity